Expression and activation of αvβ3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells

Prostate

Volumn 67, Issue 1, 2007, Pages 61-73

  Sun, Yan Xi ^a,d   Fang, Ming ^b   Wang, Jianhua ^a   Cooper, Carlton R ^c   Pienta, Kenneth J ^b   Taichman, Russell S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

^d AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

3 phosphorylation; Bone; Integrin v 3; Metastasis; Prostate cancer; SDF 1

Indexed keywords

RECEPTOR SUBUNIT; STROMAL CELL DERIVED FACTOR 1; VITRONECTIN RECEPTOR;

ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CELL ACTIVATION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

BONE NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CHEMOKINES, CXC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHAVBETA3; MALE; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN BINDING; TUMOR CELLS, CULTURED;

EID: 33845769269     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20500     Document Type: Article

References (54)

1. Balkwill F. Cancer and the chemokine network. Nature Rev Cancer 2004;4:540-550.
2. Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D, Trzyna E, Trent J, Peiper S, Zembala M, Ratajczak J, Houghton P, Janowska-Wieczorek A, Ratajczak MZ. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 2003;63(22):7926-7935.
3. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002;62:7203-7206.
4. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E, Peled A. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 2004;03-0935fje.
5. Cardones AR, Murakami T, Hwang ST. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via {beta}1 Integrin. Cancer Res 2003;63:6751-6757.
6. Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, Nie S, Umbreit J, Shim H. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
7. Spano JP, Andre F, Morat L, Sabatier L, Besse B, Combadiere C, Deterre P, Martin A, Azorin J, Valeyre D, Khayat D, Le Chevalier T, Soria JC. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: Pattern of expression and correlation with outcome. Ann Oncol 2004;15:613-617.
8. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003;425:307-311.
9. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003;63:3833-3839.
10. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. PNAS 2003;100:13513-13518.
11. Vaday G, Peehl DM, Foda HD, Zucker S. Chemokine-mediated adhesion and migration by prostate cancer cells: SDF-1a enhances cancer dissemination [abstract]. Proc AACR Annu Meet 2002;43:21-22.
12. Muller CA, Homey B, Sato H, Ge N, Catron D, Buchanan M, McClanahan T, Murphy E, Yuan W, Wagners S, Barrera J, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
13. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman N, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62:1832-1837.
14. Ponomaryov T, Peled A, Peled I, Taichman RS, Habler L, Sandbank J, Arenzana-Seisdedos G, Nagler A, Lahav M, Szyper-Kravitz M, Zipori D, Lapidot T. Increased production of SDF-1 following treatment with DNA damaging agents: Relevance for human stem cell homing and repopulation of NOD/SCID mice. J Clin Invest 2000;106:1331-1339.
15. Sun YX, Schneider A, Jung Y, Wang J, Dai J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, McCauley LK, Taichman RS. Skeletal localization and neutralization of the SDF-1 (CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005;20(2):318-329.
16. Borghesi LA, Smithson G, Kincade PW. Stromal cell modulation of negative regulatory signals that influence apoptosis and proliferation of B lineage lymphocytes. J Immunol 1997;159: 4171-4179.
17. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development [see comments]. Nature 1998; 393:595-599.
18. Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit, Ben-Hur H, Lapidot T, Alon R. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest 1999;104: 1199-1211.
19. Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP, Ben-Baruch A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001;167:4747-4757.
20. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I, van MG, Sanchez-Mateos P, Teixido J. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001;276: 45098-45105.
21. Sun Y-X, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Pienta KJ, Rubin MA, Taichman RS. The expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003;89:462-473.
22. Taichman DB, Cybulsky MI, Djaffar I, Longenecker BM, Teixido J, Rice GE, Aruffo A, Bevilacqua MP. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: Demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul 1991;2:347-355.
23. Weiss L, Orr FW, Honn KV. Interactions of cancer cells with the microvasculature during metastasis. FASEB Journal 1988;2: 12-21.
24. Lehr JE, Pienta KJ. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line [see comments]. J Natl Cancer Inst 1998;90:118-123.
25. Chattopadhyay Sengupta S. Role of alphavbeta3 integrin receptors in breast tumor. J Exp Clin Cancer Res 2001;20:585-590.
26. Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S, Trikha M. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis 2003;20(5):413-420.
27. Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 1999;59:1655-1664.
28. Cooper CR, Pienta KJ. Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A minireview. Prostate Cancer Prostatic Dis 2000;3:6-12.
29. Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH. Interactions of human prostatic epithelial cells with bone marrow endothelium: Binding and invasion. Br J Cancer 2001; 84(10):1417-1423.
30. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77:887-894.
31. Tsopanoglou NE, Andriopoulou P, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis: Involvement of alphavbeta3-integrin. Am J Physiol Cell Physiol 2002;283(5): C1501-C1510.
32. Pampori N, Hato T, Stupack DG, Aidoudi S, Cheresh DA, Nemerow GR, Shattil SJ. Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand. J Biol Chem 1999; 274(31):21609-21616.
33. Cooper CR, Sikes RA, Nicholson BE, Sun YX, Pienta KJ, Taichman RS. Cancer cells homing to bone: The significance of chemotaxis and cell adhesion. Cancer Treat Res 2004;118:291-309.
34. Cooper CR, Bhatia JK, Muenchen HJ, McLean L, Hayasaka S, Taylor J, Poncza PJ, Pienta KJ. The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clin Exp Metastasis 2002;19(1):25-33.
35. Hunziker W, Whitney JA, Mellman I. Brefeldin-A and the endocytic pathway-Possible implications for membrane traffic and sorting. FEBS Lett 1992;307:93-96.
36. Chaturvedi R, Srivastava RK, Hisatsune A, Shankar S, Lillehoj EP, Kim KC. Augmentation of Fas ligand-induced apoptosis by MUC1 mucin. Int J Oncol 2005;26:1169-1176.
37. Blystone SD, Brown EJ. Requirement of integrin beta(3) tyrosine 747 for inside-out signalling. Mol Biol Cell 1997;8: 1676.
38. Aktories K, Hall A. Botulinum Adp-Ribosyltransferase-C3 - A new tool to study low-molecular weight Gtp-binding proteins. Trends Pharmacol Sci 1989;10:415-418.
39. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer [published erratum appears in Cancer Res 1994 Jul 15;54(14):3953]. Cancer Res 1994;54:2577-2581.
40. Li X, Regezi J, Ross FP, Blystone S, Llic D, Leong SP, Ramos DM. Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro. J Cell Sci 2001;114:2665-2672.
41. Hullinger TG, McCauley LK, DeJoode ML, Somerman MJ. Effect of bone proteins on human prostate cancer cell lines in vitro. Prostate 1998;36:14-22.
42. Cohen MB, Griebling TL, Ahaghotu CA, Rokhlin OW, Ross JS. Cellular adhesion molecules in urologic malignancies. Am J Clin Pathol 1997;107:56-63.
43. Cress AE, Rabinovitz I, Zhu W, Nagle RB. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 1995;14:219-228.
44. Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia (New York) 2002;4(3): 191-194.
45. Butler B, Williams MP, Blystone SD. Ligand-dependent activation of integrin alpha(v)beta(3). J Biol Chem 2003;278: 5264-5270.
46. Gu Y, Jasti AC, Jansen M, Siefring JE. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood 2005;105:1467-1475.
47. Roland J, Murphy BJ, Ahr B, Robert-Hebmann V, Delauzun V, Nye KE, Devaux C, Biard-Piechaczyk M. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood 2003; 101:399-406.
48. Sotsios Y, Whittaker GC, Westwick J, Ward SG. The CXC chemokine stromal cell-derived factor activates a G(i)-Coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol 1999; 163:5954-5963.
49. Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA. Tumor regression by targeted gene delivery to the neovasculature. Science 2002;296:2404-2407.
50. Chandhoke SK, Williams M, Schaefer E, Zorn L, Blystone SD. beta(3) integrin phosphorylation is essential for Arp3 organization into leukocyte alpha v beta(3)-vitronectin adhesion contacts. J Cell Sci 2004;117:1431-1441.
51. Doyonnas R, Chan JYH, Butler LH, Rappold I, Lee-Prudhoe JE, Zannettino ACW, Simmons PJ, Buhring HJ, Levesque JP, Watt SM. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol 2000;165:840-851.
52. Havens AM, Jung Y, Sun YX, Taichman RS. The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 2006;6:195.
53. Lawler KM, Foran E, O'sullivan G, Long A, Kenny D. The mobility and invasiveness of metastatic esophageal cancer is potentiated by shear stress in a ROCK and Ras dependent manner. Am J Physiol Cell Physiol 2006 Apr 26; [Epub ahead of print] PMID: 16641163 [PubMed-as supplied by publisher].
54. Lawler K, Meade G, O'Sullivan G, Kenny D. Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3. Am J Physiol Cell Physiol. 2004 Nov;287(5):C1320-7. Epub 2004 Jul 7. PMID: 15240342 [PubMed-indexed for MEDLINE].